Beyond morphology: functional imaging of the liver with gadoxetic acid-enhanced magnetic resonance imaging
Authors:
- Eleonora Salles-SilvaESEleonora Salles-Silva
- Sthefane Louise Gomes NunesSNSthefane Louise Gomes Nunes
- Rosana Souza RodriguesRRRosana Souza Rodrigues
- Antonio Luis Eiras de AraújoAAAntonio Luis Eiras de Araújo
- Renata Mello PerezRPRenata Mello Perez
- Giuseppe D’IPpolitoGDGiuseppe D’IPpolito
- Caroline Lorenzoni Almeida GhezziCGCaroline Lorenzoni Almeida Ghezzi
- José Hugo Mendes LuzJLJosé Hugo Mendes Luz
- Viviane Brandão AmorimVAViviane Brandão Amorim
- Daniella Braz ParenteDPDaniella Braz Parente
Open Access
- 22 June 2026
- journal article
- review article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (12) , 6218-6238
Abstract
Chronic liver diseases (CLD) are highly prevalent. Early diagnosis and staging of hepatic dysfunction are essential for optimal treatment decisions. While conventional imaging primarily evaluates morphology and focal liver lesions, gadoxetic acid (GA)-enhanced magnetic resonance imaging (MRI) provides additional functional information by assessing hepatocellular uptake and biliary excretion. Hepatocyte uptake depends largely on sinusoidal membrane transporters (OATP1B1/1B3), while excretion into bile canaliculi is mediated by MRP2. In liver dysfunction and cirrhosis, both processes may be impaired, resulting in measurable changes on hepatobiliary phase (HBP). This review summarizes the biological rationale, MRI protocol, and quantitative indices, including RLE, REI, HUI, rHUI, SIR, CUI, LSI, as well as the qualitative Functional Liver Imaging Score (FLIS). It also highlights key clinical applications, including prognostication in advanced CLD, preoperative risk stratification for post-hepatectomy liver failure, evaluation in the setting of embolization and locoregional therapies, and transplant assessment, along with emerging roles in metabolic dysfunction-associated steatotic liver disease. Finally, future directions are discussed, including T1 mapping and AI-based whole-liver quantification.Keywords
Funding Information
- Universidade Federal do Rio de Janeiro
This publication has 51 references indexed in Scilit:
- Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept StudyRadiology, 2014
- Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver functionEuropean Radiology, 2013
- Usefulness of Gd‐EOB‐DTPA‐enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitisJournal of Magnetic Resonance Imaging, 2012
- Primovist, Eovist: What to expect?Journal of Hepatology, 2012
- Liver TransplantationInvestigative Radiology, 2012
- Quantitative Evaluation of Liver Function with Use of Gadoxetate Disodium–enhanced MR ImagingRadiology, 2011
- Cirrhotic Rat Liver: Reference to Transporter Activity and Morphologic Changes in Bile Canaliculi—Gadoxetic Acid–enhanced MR ImagingRadiology, 2010
- Gadoxetate Disodium–Enhanced MRI of the Liver: Part 2, Protocol Optimization and Lesion Appearance in the Cirrhotic LiverAmerican Journal of Roentgenology, 2010
- Biliary MR Imaging with Gd-EOB-DTPA and Its Clinical ApplicationsRadioGraphics, 2009
- Primary sclerosing cholangitis--approach to diagnosis.2007